| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.051 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |